Fishman, D A <br/><br/>
Effect of combination chemotherapy with cisplatin and cyclophosphamide on human immunodeficiency virus type-1 surrogate markers in a patient with advanced epithelial ovarian cancer.  [electronic resource] 

 -  Gynecologic oncology  Apr 1995 
 - 105-8 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>0090-8258 
<br/><br/><label>Standard No.: </label>10.1006/gyno.1995.1105  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Biomarkers--analysis<br/>Chemotherapy, Adjuvant<br/>Cisplatin--therapeutic use<br/>Cyclophosphamide--therapeutic use<br/>Cystadenocarcinoma, Serous--complications<br/>Female<br/>HIV Infections--complications<br/>HIV-1<br/>Humans<br/>Ovarian Neoplasms--complications